Re: 'Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes' by Nutman et al.

Subjects

Subjects :

Anti-Bacterial Agents pharmacology
Anti-Bacterial Agents therapeutic use
Carbapenems pharmacology
Humans
Meropenem pharmacology
Acinetobacter Infections drug therapy
Colistin

Details

Language :

English

ISSN :

1469-0691

Volume :

27

Issue :

3

Database :

MEDLINE

Journal :

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Publication Type :

Editorial & Opinion

Accession number :

32771641

Full Text :

https://doi.org/10.1016/j.cmi.2020.07.044